1. Stanaway JD, Flaxman AD, Naghavi M, et al. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. Lancet. 2016; 388:1081–1088. DOI:
10.1016/S0140-6736(16)30579-7. PMID:
27394647. PMCID:
PMC5100695.
3. Nelson PK, Mathers BM, Cowie B, et al. 2011; Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet. 378:571–583. DOI:
10.1016/S0140-6736(11)61097-0. PMID:
21802134. PMCID:
PMC3285467.
4. El-Ghitany EM, Abdel Wahab MM, Abd El-Wahab EW, Hassouna S, Farghaly AG. 2015; A comprehensive hepatitis C virus risk factors meta-analysis (1989-2013): do they differ in Egypt? Liver Int. 35:489–501. DOI:
10.1111/liv.12617. PMID:
24923487.
5. Saks M. 1994. Professions and the public interest: medical power, altruism and alternative medicine. Routledge;London:
7. Brady S, McEvoy J, Dommerholt J, Doody C. 2014; Adverse events following trigger point dry needling: a prospective survey of chartered physiotherapists. J Man Manip Ther. 22:134–140. DOI:
10.1179/2042618613Y.0000000044. PMID:
25125935. PMCID:
PMC4101552.
8. Mitrovic N, Delic D, Markovic-Denic L, et al. 2015; Seroprevalence and risk factors for hepatitis C virus infection among blood donors in Serbia: A multicentre study. Dig Liver Dis. 47:572–576. DOI:
10.1016/j.dld.2015.03.019. PMID:
25882212.
9. Rezaei N, Amini-Kafiabad S, Maghsudlu M, Abolghasemi H. 2016; Risk factor analysis of hepatitis C virus seropositivity in Iranian blood donors: a case-control study. Transfusion. 56:1891–1898. DOI:
10.1111/trf.13660. PMID:
27273657.
10. Jafari S, Copes R, Baharlou S, Etminan M, Buxton J. 2010; Tattooing and the risk of transmission of hepatitis C: a systematic review and meta-analysis. Int J Infect Dis. 14:e928–e940. DOI:
10.1016/j.ijid.2010.03.019. PMID:
20678951.
11. Lim SH, Lee S, Lee YB, et al. 2022; Increased prevalence of transfusion-transmitted diseases among people with tattoos: A systematic review and meta-analysis. PLoS One. 17:e0262990. DOI:
10.1371/journal.pone.0262990. PMID:
35085358. PMCID:
PMC8794209.
12. Tohme RA, Holmberg SD. 2012; Transmission of hepatitis C virus infection through tattooing and piercing: a critical review. Clin Infect Dis. 54:1167–1178. DOI:
10.1093/cid/cir991. PMID:
22291098. PMCID:
PMC4613802.
13. Van Remoortel H, Moorkens D, Avau B, Compernolle V, Vandekerckhove P, De Buck E. 2019; Is there a risk of transfusion-transmissible infections after percutaneous needle treatments in blood donors? A systematic review and meta-analysis. Vox Sang. 114:297–309. DOI:
10.1111/vox.12780. PMID:
30972765.
14. Modesti PA, Reboldi G, Cappuccio FP, et al. 2016; Panethnic differences in blood pressure in Europe: A systematic review and meta-analysis. PLoS One. 11:e0147601. DOI:
10.1371/journal.pone.0147601. PMID:
26808317. PMCID:
PMC4725677.
17. Salama BM. 2020; Risk factors associated with HCV infection among adults in Damietta Governorate, Egypt. Ann Clin Anal Med. 11:519–522. DOI:
10.4328/ACAM.20149.
18. Mohd Suan MA, Said SM, Lim PY, Azman AZF, Abu Hassan MR. 2019; Risk factors for hepatitis C infection among adult patients in Kedah state, Malaysia: A case-control study. PLoS One. 14:e0224459. DOI:
10.1371/journal.pone.0224459. PMID:
31661525. PMCID:
PMC6818779.
19. Wasitthankasem R, Vichaiwattana P, Siripon N, et al. 2018; Birth-cohort HCV screening target in Thailand to expand and optimize the national HCV screening for public health policy. PLoS One. 13:e0202991. DOI:
10.1371/journal.pone.0202991. PMID:
30138441. PMCID:
PMC6107264.
20. Mac Donald-Ottevanger MS, Vreden S, van der Helm JJ, et al. 2016; Prevalence, determinants and genetic diversity of hepatitis C virus in the multi-ethnic population living in Suriname. Virology. 499:114–120. DOI:
10.1016/j.virol.2016.07.001. PMID:
27657832.
21. Sohn HS, Kim JR, Ryu SY, et al. 2016; Risk factors for hepatitis C virus (HCV) infection in areas with a high prevalence of HCV in the Republic of Korea in 2013. Gut Liver. 10:126–132. DOI:
10.5009/gnl14403. PMID:
26260752. PMCID:
PMC4694744.
22. Huang P, Zhu LG, Zhai XJ, et al. Hepatitis C virus infection and risk factors in the general population: a large community-based study in eastern China, 2011-2012. Epidemiol Infect. 2015; 143:2827–2836. DOI:
10.1017/S0950268814003719. PMID:
25600557. PMCID:
PMC9151013.
23. Huang Y, Guo N, Yu Q, et al. 2015; Risk factors for hepatitis B and C infection among blood donors in five Chinese blood centers. Transfusion. 55:388–394. DOI:
10.1111/trf.12850. PMID:
25382751.
24. Carney K, Dhalla S, Aytaman A, Tenner CT, Francois F. 2013; Association of tattooing and hepatitis C virus infection: a multicenter case-control study. Hepatology. 57:2117–2123. DOI:
10.1002/hep.26245. PMID:
23315899.
25. Kin KC, Lin B, Ha NB, et al. 2013; High proportion of hepatitis C virus in community Asian American patients with non-liver-related complaints. J Clin Gastroenterol. 47:367–371. DOI:
10.1097/MCG.0b013e3182688b3e. PMID:
23090039.
26. Seong MH, Kil H, Kim YS, et al. 2013; Clinical and epidemiological features of hepatitis C virus infection in South Korea: a prospective, multicenter cohort study. J Med Virol. 85:1724–1733. DOI:
10.1002/jmv.23661. PMID:
23813472.
27. Ahmed F, Irving WL, Anwar M, Myles P, Neal KR. 2012; Prevalence and risk factors for hepatitis C virus infection in Kech District, Balochistan, Pakistan: most infections remain unexplained. A cross-sectional study. Epidemiol Infect. 140:716–723. DOI:
10.1017/S0950268811001087. PMID:
21672295.
28. Kim JY, Cho J, Hwang SH, et al. 2012; Behavioral and healthcare-associated risk factors for chronic hepatitis C virus infection in Korea. J Korean Med Sci. 27:1371–1377. DOI:
10.3346/jkms.2012.27.11.1371. PMID:
23166420. PMCID:
PMC3492673.
29. He Y, Zhang J, Zhong L, et al. 2011; Prevalence of and risk factors for hepatitis C virus infection among blood donors in Chengdu, China. J Med Virol. 83:616–621. DOI:
10.1002/jmv.22010. PMID:
21328375.
30. Vickery K, Tawk HM, Bisset L, Selby W, Cossart YE. 2009; Hepatitis C virus infection rates and risk factors in an Australian hospital endoscopy cohort. Aust N Z J Public Health. 33:442–448. DOI:
10.1111/j.1753-6405.2009.00426.x. PMID:
19811480.
32. Karmochkine M, Carrat F, Dos Santos O, Cacoub P, Raguin G. 2006; A case-control study of risk factors for hepatitis C infection in patients with unexplained routes of infection. J Viral Hepat. 13:775–782. DOI:
10.1111/j.1365-2893.2006.00742.x. PMID:
17052278.
33. Méndez-Sánchez N, Motola-Kuba D, Zamora-Valdés D, et al. 2006; Risk factors and prevalence of hepatitis virus B and C serum markers among nurses at a tertiary-care hospital in Mexico City, Mexico: a descriptive study. Ann Hepatol. 5:276–280. DOI:
10.1016/S1665-2681(19)31988-X. PMID:
17151581.
34. Dominitz JA, Boyko EJ, Koepsell TD, et al. 2005; Elevated prevalence of hepatitis C infection in users of United States veterans medical centers. Hepatology. 41:88–96. DOI:
10.1002/hep.20502. PMID:
15619249.
36. Yildirim B, Tahan V, Ozaras R, et al. 2005; Hepatitis C virus risk factors in the Turkish community. Dig Dis Sci. 50:2352–2355. DOI:
10.1007/s10620-005-3061-3. PMID:
16416188.
37. Lee PL, Wang JH, Tung HD, Lee CM, Lu SN. 2004; A higher than expected recovery rate from hepatitis C infection amongst adolescents: a community study in a hepatitis C-endemic township in Taiwan. Trans R Soc Trop Med Hyg. 98:367–372. DOI:
10.1016/j.trstmh.2003.10.013. PMID:
15099993.
38. Brandão AB, Fuchs SC. 2002; Risk factors for hepatitis C virus infection among blood donors in southern Brazil: a case-control study. BMC Gastroenterol. 2:18. DOI:
10.1186/1471-230X-2-18. PMID:
12169200. PMCID:
PMC122085.
39. Brillman JC, Crandall CS, Florence CS, Jacobs JL. 2002; Prevalence and risk factors associated with hepatitis C in ED patients. Am J Emerg Med. 20:476–480. DOI:
10.1053/ajem.2002.32642. PMID:
12216048.
40. Kim YS, Ahn YO, Lee HS. 2002; Risk factors for hepatitis C virus infection among Koreans according to the hepatitis C virus genotype. J Korean Med Sci. 17:187–192. DOI:
10.3346/jkms.2002.17.2.187. PMID:
11961301. PMCID:
PMC3054844.
41. Shin HR, Kim JY, Kim JI, et al. 2002; Hepatitis B and C virus prevalence in a rural area of South Korea: the role of acupuncture. Br J Cancer. 87:314–318. DOI:
10.1038/sj.bjc.6600436. PMID:
12177801. PMCID:
PMC2364222.
42. Domínguez A, Bruguera M, Vidal J, Plans P, Salleras L. 2001; Community-based seroepidemiological survey of HCV infection in Catalonia, Spain. J Med Virol. 65:688–693. DOI:
10.1002/jmv.2091. PMID:
11745932.
43. Haley RW, Fischer RP. 2001; Commercial tattooing as a potentially important source of hepatitis C infection. Clinical epidemiology of 626 consecutive patients unaware of their hepatitis C serologic status. Medicine (Baltimore). 80:134–151. DOI:
10.1097/00005792-200103000-00006. PMID:
11307589.
46. Langevin HM, Schnyer R, MacPherson H, et al. 2015; Manual and electrical needle stimulation in acupuncture research: pitfalls and challenges of heterogeneity. J Altern Complement Med. 21:113–128. DOI:
10.1089/acm.2014.0186. PMID:
25710206. PMCID:
PMC4855731.
47. Luo J, Xu H, Liu B. 2015; Real world research: a complementary method to establish the effectiveness of acupuncture. BMC Complement Altern Med. 15:153. DOI:
10.1186/s12906-015-0676-6. PMID:
25997850. PMCID:
PMC4440554.
48. Raffaele A, Valenti M, Iovenitti M, et al. 2001; High prevalence of HCV infection among the general population in a rural area of central Italy. Eur J Epidemiol. 17:41–46. DOI:
10.1023/A:1010932832190. PMID:
11523574.